View Post Disseminated Gonococcal Infection: A Potential Marker of Failing Sexually Transmitted Infection Control and Prevention Services. Sexually Transmitted Infections, 98(3): 233. In by AHFJuly 1, 2021
View Post Were We Prepared for PrEP? Five Years of Implementation. AIDS, 31(16): 2303-2305. In by AHFOctober 1, 2017
View Post Clinical Impact and Cost of Laboratory Monitoring Need Review Even in Resource-Rich Setting. Journal of Acquired Immune Deficiency Syndromes, 56(3): e97-e98. In by AHFMarch 1, 2011
View Post The 104 Day Report: A Successful Intervention of Improving Patient Retention. Clinical Infectious Diseases, 51(7): 868-869. In by AHFOctober 1, 2010
View Post DART and Laboratory Monitoring of HIV Treatment. The Lancet, 375 (9719): 979. In by AHFMarch 1, 2010
View Post Avoid a Different Standard of Care When Applying Results of Development of Antiretroviral Therapy in Africa (DART) Study. Journal of Acquired Immune Deficiency Syndromes, 53(1): 153-154. In by AHFJanuary 1, 2010
View Post Efficacy of an Individualized Adherence Support Program with Contingent Reinforcement among Nonadherent HIV-Positive Patients: Results from a Randomized Trial. Journal of the International Association of Physicians in AIDS Care, 5(4): 143-150. In by AHFDecember 1, 2006
